The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 18, 2025
Filed:
Nov. 06, 2015
Applicants:
Nacuity Pharmaceuticals, Inc., Fort Worth, TX (US);
The Johns Hopkins University, Baltimore, MD (US);
Inventors:
Peter A. Campochiaro, Baltimore, MD (US);
Daniel Hartman, Fort Worth, TX (US);
Assignees:
Nacuity Pharmaceuticals, Inc., Fort Worth, TX (US);
The Johns Hopkins University, Baltimore, MD (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/16 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/198 (2006.01); A61K 45/06 (2006.01); A61P 27/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/16 (2013.01); A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 31/198 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01);
Abstract
The present invention includes a method for the treatment of retinitis pigmentosa in a human that comprises administering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA). In accordance with an embodiment, the present invention provides a method for the treatment of retinitis pigmentosa in an animal that comprises administering to the animal a therapeutically effective amount of N-acetylcystein amide (NACA).